NCT/Study#

NCT03467867 /

PRO2018-0577

A Phase II Study of Venetoclax and Rituximab/hyaluronidase human in Relapsed/Refractory CLL

A Phase II Study of Venetoclax and Rituximab/hyaluronidase human in Relapsed/Refractory CLL

DISEASE GROUP:
Lymphoma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: